TY  - JOUR
AU  - Dakin, Helen
AU  - Rombach, Ines
AU  - Dritsaki, Melina
AU  - Gray, Alastair
AU  - Ball, Catherine
AU  - Lamb, Sarah E.
AU  - Nanchahal, Jagdeep
DO  - doi:10.1302/2633-1462.311.BJO-2022-0103.R2
UR  - https://doi.org/10.1302/2633-1462.311.BJO-2022-0103.R2
TI  - Cost-effectiveness of adalimumab for early-stage Dupuytren’s disease
T2  - Bone & Joint Open
VL  - 3
IS  - 11
PY  - 2022
SP  - 898
EP  - 906
ER  -